Cargando…

Deficient activation of CD95 (APO-1/ Fas)-mediated apoptosis: a potential factor of multidrug resistance in human renal cell carcinoma

The pronounced resistance of human renal cell carcinoma (RCC) to anticancer-induced apoptosis has primarily been related to the expression of P-glycoprotein and effective drug detoxification mechanisms. Because the CD95 system has recently been identified as a key mediator of anticancer drug-induced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramp, U, Dejosez, M, Mahotka, C, Czarnotta, B, Kalinski, T, Wenzel, M, Lorenz, I, Müller, M, Krammer, P, Gabbert, H E, Gerharz, C D
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363218/ https://www.ncbi.nlm.nih.gov/pubmed/10839301 http://dx.doi.org/10.1054/bjoc.2000.1155

Ejemplares similares

Apoptosis induction in renal cell carcinoma by TRAIL and γ-radiation is impaired by deficient caspase-9 cleavage
por: Ramp, U, et al.
Publicado: (2003)

TRAIL-β and TRAIL-γ: two novel splice variants of the human TNF-related apoptosis-inducing ligand (TRAIL) without apoptotic potential
por: Krieg, A, et al.
Publicado: (2003)

Significance of serum-soluble CD95 (Fas/APO-1) on prognosis in renal cell cancer patients
por: Kimura, M, et al.
Publicado: (1999)

Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas
por: Yan, Y, et al.
Publicado: (2004)

Signaling through the Death Receptor CD95 (APO-1/FAS)
por: Peter, Marcus E.
Publicado: (2001)

p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
por: Müller, Martina, et al.
Publicado: (1998)

PIDDosome Expression and the Role of Caspase-2 Activation for Chemotherapy-Induced Apoptosis in RCCs
por: Heikaus, Sebastian, et al.
Publicado: (2010)

Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage
Publicado: (1995)

Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression
por: Yamana, K, et al.
Publicado: (2005)

Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase
Publicado: (1994)

Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression
por: Krieg, A, et al.
Publicado: (2002)

Heterogeneous response to differentiation induction with different polar compounds in a clonal rat rhabdomyosarcoma cell line (BA-HAN-1C).
por: Gerharz, C. D., et al.
Publicado: (1989)

Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain
Publicado: (1996)

Protein kinase C in human renal cell carcinomas: role in invasion and differential isoenzyme expression
por: Engers, R, et al.
Publicado: (2000)

HA14-1 is Able to Reconstitute the Impaired Mitochondrial Pathway of Apoptosis in Renal Cell Carcinoma Cell Lines
por: Heikaus, Sebastian, et al.
Publicado: (2008)

Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)- mediated T cell apoptosis
Publicado: (1996)

Chromophilic renal cell carcinoma: cytomorphological and cytogenetic characterisation of four permanent cell lines.
por: Gerharz, C. D., et al.
Publicado: (1996)

Ultraviolet Light Induces Apoptosis via Direct Activation of CD95 (Fas/APO-1) Independently of Its Ligand CD95L
por: Aragane, Yoshinori, et al.
Publicado: (1998)

Caspase-8 activity has an essential role in CD95/Fas-mediated MAPK activation
por: Kober, A M M, et al.
Publicado: (2011)

The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma
por: Ito, Y, et al.
Publicado: (2000)

Absence of Bcl-2 and Fas/CD95/APO-1 predicts the response to immunotherapy in metastatic renal cell carcinoma
por: Maruyama, R, et al.
Publicado: (2006)

A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice
Publicado: (1996)

Fas/CD95 Deficiency in Apc(Min/+) Mice Increases Intestinal Tumor Burden
por: Guillen-Ahlers, Hector, et al.
Publicado: (2010)

CD95/Fas promotes tumour growth
por: Chen, Lina, et al.
Publicado: (2010)

The Central Executioner of Apoptosis: Multiple Connections between Protease Activation and Mitochondria in Fas/APO-1/CD95- and Ceramide-induced Apoptosis
por: Susin, Santos A., et al.
Publicado: (1997)

Growth inhibition in clonal subpopulations of a human epithelioid sarcoma cell line by retinoic acid and tumour necrosis factor alpha.
por: Engers, R., et al.
Publicado: (1996)

Asymmetric dimethylarginine attenuates serum starvation-induced apoptosis via suppression of the Fas (APO-1/CD95)/JNK (SAPK) pathway
por: Li, H, et al.
Publicado: (2013)

Fractionated γ-irradiation renders tumour cells more responsive to apoptotic signals through CD95
por: Sheard, M A, et al.
Publicado: (1999)

Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells
por: Ragnarsson, G B, et al.
Publicado: (2000)

Antiinflammatory Effects of CD95 Ligand (FasL)-induced Apoptosis
por: Gao, Yakun, et al.
Publicado: (1998)

CD95/Fas, Non-Apoptotic Signaling Pathways, and Kinases
por: Le Gallo, Matthieu, et al.
Publicado: (2017)

CD95/Fas ligand mRNA is toxic to cells
por: Putzbach, Will, et al.
Publicado: (2018)

Differential expression of Fas receptors (CD95) and Fas ligands (CD95L) in HIV infected and exposed uninfected children in Cameroon versus unexposed children
por: Dambaya, Béatrice, et al.
Publicado: (2019)

CD95/Fas suppresses NF-κB activation through recruitment of KPC2 in a CD95L/FasL-independent mechanism
por: Guégan, Jean-Philippe, et al.
Publicado: (2021)

CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway
Publicado: (1995)

Fas receptor (CD95) & Fas ligand (CD178) expression in patients with tobacco-related intraoral squamous cell carcinoma
por: Das, Satya N., et al.
Publicado: (2011)

The Peripheral Deletion of Autoreactive CD8(+) T Cells Induced by Cross-presentation of Self-antigens Involves Signaling through CD95 (Fas, Apo-1)
por: Kurts, Christian, et al.
Publicado: (1998)

Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils
Publicado: (1996)

Super-Resolution Imaging of Fas/CD95 Reorganization Induced by Membrane-Bound Fas Ligand Reveals Nanoscale Clustering Upstream of FADD Recruitment
por: Frazzette, Nicholas, et al.
Publicado: (2022)

Levels of soluble Fas/APO-1 in patients with Behçet's disease.
por: Hamzaoui, K, et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_0iaerbavr5g24fptl85ctc9049